DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Brandes AA, Tosoni A, Basso U. et al.
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
J Clin Oncol 2004; 22: 4779-4786
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.